Viread-tenvir (300 mg)

Gilead Science, INC

“Viread” contains the Drug / Molecule “Tenofovir Disoproxil”. Viread belongs to a class of antiviral medications called reverse transcriptase inhibitors by competing with the natural substrate, deoxyadenosine 5′-triphosphate and by DNA chain termination.

Indication

Viread is used in combination with other antiviral medications in patients with acquired immunodeficiency syndrome (AIDS). Viread is also used for the treatment of chronic hepatitis B infection.

Note

SIDE EFFECTS :

  • Common side effects include nausea, rash, diarrhea, headache, pain, depression and weakness.
  • Severe side effects include high blood lactate and an enlarged liver.
  • Long term use of Viread is associated with nephrotoxicity and bone loss.

INTERACTIONS :

  • Tenofovir interacts with Didnosine and HIV-1 protease inhibitors. Tenofovir increases Didanosine concentrations and can result in adverse effects such as pancreatitis and neuropathy.
  • Tenofovir also interacts with HIV-1 protease inhibitors such as Atazanavir, by decreasing Atazanavir concentrations while increasing Tenofovir concentrations.

OVERDOSE :

  • Do not use more than prescribed dose.
  • If you suspect you may have overdosed, call your healthcare provider.
  • Do not take extra dose to make up for the missed dose.

Precaution

  • Viread is a prescription drug and should be used under proper medical guidance and advice.
  • Caution to be taken if patient suffering from renal impairment, hepatomegaly or at other liver disease.